Seven Eight Capital’s Dynavax Technologies DVAX Stock Holding History

Seven Eight Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40,029	Closed	-$591K	–	675
2023 Q3	$591K	Buy	+40,029	New	+$563K	0.07%	357

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Seven Eight Capital's DVAX Position: Q4 2023 in Review

Seven Eight Capital sold out of Dynavax Technologies (DVAX) in Q4 2023, closing a stake of 40,029 shares — an estimated $591K sold.

Seven Eight Capital first reported a position in DVAX in Q3 2023 and held it in 1 quarter. The position peaked at $591K in Q3 2023. 246 funds tracked by Wall St. Rank hold DVAX as of Q4 2023.

Seven Eight Capital reported no remaining Dynavax Technologies position as of Q4 2023 after selling out during the quarter.
Seven Eight Capital sold 40,029 Dynavax Technologies shares in Q4 2023, an estimated $591K.
Seven Eight Capital first reported a position in Dynavax Technologies in Q3 2023 and held it in 1 quarter.
Seven Eight Capital's Dynavax Technologies position peaked at $591K in Q3 2023.
246 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2023.

Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.